Clinical trials: Coronary Stent Occlusion
Coronary Artery Disease Aggravated, Myocardial Ischemia
Biofreedom Prospective Multicenter Observational Registry
LEADERS-FREE trial demonstrated the safety and efficacy of polymer-free drug-coated stent (Biofreedom, Biosensors International Technologies, Singapore) in patients with high bleeding risk.
- Conditions
- Coronary Artery Disease Aggravated, Myocardial Ischemia, Myocardial Infarction
- Trial name
- NCT03045848
- Testing
- Biofreedom drug-coated stent
- Where
- 16 sites in South Korea
- Volunteers
- 194 people
- Sponsor
- Wonju Severance Christian Hospital
Coronary Artery Disease (CAD), Ischemic Heart Disease
ANGIOLITE PMCF Study ( rEPIC04F )
Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Angiolite sirolimus eluting stent to meet EU Medical Device regulation (MDR)…
- Trial name
- rEPIC04F (NCT05292014)
- Testing
- ANGIOLITE
- Where
- 6 sites in Spain
- Volunteers
- 81 people
- Sponsor
- Fundación EPIC
Coronary Artery Disease
Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
The objective of this study is to evaluate the safety and long-term effectiveness of coronary stenting with the everolimus-eluting stent (EES) and to determine clinical device and procedural success during commercial use of EES…
- Trial name
- NCT00960648
- Testing
- Xience/Promus, Cypher
- Where
- 18 sites in South Korea
- Volunteers
- 3,056 people
- Sponsor
- Seoul National University Hospital
Coronary Artery Disease
EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding
RATIONALE: Transradial coronary stenting is associated with less risk of access site complications and bleeding compared to femoral approach. Major bleeding post-PCI is a strong independent predictor of mortality and MACE.
- Trial name
- EASY-B2B (NCT01084993)
- Testing
- Bivalirudin, Heparin
- Where
- Canada
- Volunteers
- 2,000 people
- Sponsor
- Laval University
Coronary Artery Disease, Coronary Atherosclerosis
Everolimus Stent in Patients With Coronary Artery Disease (CAD)
Aim of the study is to compare the everolimus eluting stent and sirolimus eluting stent in all comers PCI eligible patients
- Trial name
- RACES (NCT01182649)
- Testing
- coronary stent, stent
- Where
- Italy
- Volunteers
- 600 people
- Sponsor
- San Giuseppe Moscati Hospital
Coronary Artery Disease
Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
Thrombotic event is one of the most serious complications of coronary artery disease, which often result in myocardial infarction and even death.
- Trial name
- spirit (NCT01371058)
- Testing
- high maintenance clopidogrel, routine dual antiplatelet, policosanol plus dual antiplatelet
- Where
- China
- Volunteers
- 350 people
- Sponsor
- Shenyang Northern Hospital
Coronary Artery Disease, Chronic Stable Angina
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
This study aims to demonstrate that the BioFreedom™ Ultra Drug Coated Stent (DCS) is non-inferior to the BioFreedom™ DCS, with respect to in-stent late lumen loss, and that it has safety characteristics similar to the BioFreedom™…
- Conditions
- Coronary Artery Disease, Chronic Stable Angina, Unstable Angina, Silent Ischemia
- Trial name
- NCT06657326
- Testing
- BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent, BioFreedom™ stainless steel Biolimus A9™-coated stent
- Where
- 6 sites in Malaysia
- Volunteers
- 444 people
- Sponsor
- Biosensors Europe SA
Coronary Artery Disease
Hydroxyapatite Active Pro Healing Clinical Trial Program
The purpose of this first feasibility study is to evaluate the performance of Vesta™ \& VestaCOR™ (Hydroxy-Apetite coated GenX) stent in de novo native coronary artery lesions.
- Trial name
- HApFIM (NCT00474084)
- Testing
- Intravascular Coronary Stent
- Volunteers
- 70 people
- Sponsor
- BioSync Scientific Pvt. Ltd.
Vascular Disease, Myocardial Ischemia
A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese Population
The purpose of this study is to evaluate the safety and effectiveness of the AVJ-09-385 Small Vessel Everolimus Eluting Coronary Stent System (EECSS) (2.25 mm diameter stent) in treatment of subjects with ischemic heart disease…
- Conditions
- Vascular Disease, Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease
- Trial name
- SV JAPAN (NCT01115933)
- Testing
- XIENCE PRIME SV EECSS
- Where
- 14 sites in Japan
- Volunteers
- 65 people
- Sponsor
- Abbott Medical Devices
Coronary Artery Disease
Influence of Vessel Wall Calcification on Early Stent Strut Healing
To assess the influence of superficial calcium on the early endothelialization (1 month) of the struts of the Xience Skypoint stent (comparing struts with underlying superficial calcium to struts without underlying calcification)
- Trial name
- CaOCT (NCT06631755)
- Testing
- Xience Skypoint stent over calcified coronary lesions
- Where
- Spain
- Volunteers
- 40 people
- Sponsor
- Fundación EPIC
Coronary Artery Disease
Safety and Effectiveness of the Coronary Momo Stent
This study evaluates the safety and effectiveness of the Momo Cobalt Chromium stent system for the treatment of single de novo lesions in a native coronary artery.
- Trial name
- NCT01535625
- Testing
- Momo stent
- Where
- 6 sites in Belgium
- Volunteers
- 100 people
- Sponsor
- be Medical
Coronary Artery Disease, Stable Angina
Randomized Controlled Study of the Traditional Percutaneous Coronary Intervention and Intervention Using Optical Coherence Tomography of Incomplete Stent Adhesion and Extent of the Formation of Neointima by Resolute Zotarolimus-eluting Stent Insertion
Optical coherence tomography (OCT) after the stent procedure to improve the adhesion and expansion, or incomplete uncovered struts attached to the main track.
- Conditions
- Coronary Artery Disease, Stable Angina, Unstable Angina
- Trial name
- NCT01869842
- Testing
- percutaneous coronary intervention, OCT-guided percutaneous coronary intervention
- Where
- South Korea
- Volunteers
- 115 people
- Sponsor
- Yonsei University
Coronary Artery Disease, Coronary Restenosis
Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure.
- Trial name
- NCT00248066
- Testing
- RESTEN-MP
- Where
- 3 sites in Germany
- Volunteers
- 50 people
- Sponsor
- Sarepta Therapeutics, Inc.
Coronary Artery Disease
Does Co-registration of OCT and Angiography Reduce Geographic Miss of Stent Implantation?
The purpose of this study is to determine whether co-registration of OCT and angiography reduce geographic miss defined as stent edge dissection or significant residual stenosis at stent edge after stent implantation during…
- Trial name
- NCT02671123
- Testing
- Coronary PCI with OCT with Co Registration, Coronary PCI with OCT without Co Registration
- Where
- United States
- Volunteers
- 200 people
- Sponsor
- St. Francis Hospital, New York
Coronary Artery Disease
China Made Sirolimus Eluting Stent for Intermediate Lesion
Sirolimus-eluting stent (SES) has been proven to improve outcomes in patients with significant coronary artery diseae(> 70% lumen diameter narrowing).
- Trial name
- SESIL (NCT01375296)
- Testing
- China-made SES (Firebird 2 and Excel), routine medicine
- Where
- China
- Volunteers
- 600 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Coronary Artery Disease, Arterial Occlusive Diseases
IRIS-Onyx Cohort in the IRIS-DES Registry
The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.
- Conditions
- Coronary Artery Disease, Arterial Occlusive Diseases, Cardiovascular Diseases, Percutaneous Transluminal Angioplasty
- Trial name
- IRIS-Onyx (NCT02593994)
- Testing
- Onyx Drug Eluting Stent group
- Where
- 31 sites in South Korea
- Volunteers
- 4,500 people
- Sponsor
- Seung-Jung Park
Coronary Artery Disease
Effects of DES Platforms on Markers of Endothelial Damage and Inflammation
Percutaneous coronary intervention (PCI) with stenting may induce endothelial damage/dysfunction and inflammatory reactions, which in turn delay healing and endothelialization and may lead to restenosis and atherosclerosis within…
- Trial name
- PLATFORM (NCT01489202)
- Testing
- platinum chromium everolimus-eluting stent, cobalt chromium everolimus-eluting stent
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University of Roma La Sapienza
Aortic Coarctation, Pulmonary Artery Stenosis
First-in-human Clinical Trial to Assess Safety and Efficacy of the CardiaZn Bioresorbable Stent in Children With Pulmonary Artery Stenosis and Aortic Coarctation
This study evaluates the safety and effectiveness of the CardiaZn stent, a novel bioresorbable stent designed specifically for infants and children with congenital cardiovascular conditions.
- Trial name
- Pediasorb (NCT07628101)
- Testing
- CardiaZn Bioresorbable Stent
- Volunteers
- 45 people
- Sponsor
- PediaStent LLC
Coronary Artery Disease
Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)
The objective of this study is to allow treatment with the sirolimus-eluting Bx VELOCITYTM stent in patients with a serious disease or condition for which there is no generally acceptable alternate treatment available.
- Trial name
- NCT00231244
- Testing
- CYPHER Sirolimus-Eluting Coronary Stent
- Where
- United States
- Volunteers
- 252 people
- Sponsor
- Cordis US Corp.
Ischemic Heart Disease, Coronary Atherosclerosis
The SOURT OUT IV TRIAL
In a randomized study the Xience V coroary artery stent may be non inferior to the Cypher Select+ coronary stents in the treatment of unselected patients with coronary artery disease.
- Conditions
- Ischemic Heart Disease, Coronary Atherosclerosis, Percutaneous Coronary Intervention
- Trial name
- SORT OUT IV (NCT00552877)
- Testing
- Percutaneous coronary intervention (Xience V stent)
- Where
- Denmark
- Volunteers
- 2,678 people
- Sponsor
- Odense University Hospital